Cytokinetics Inc (NASDAQ:CYTK) has 416 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 869,376 | 5.60% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -283,895 | -2.17% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 8,026,280 | 42.07% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -431,613 | -55.69% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 191,336 | 1.61% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | -963,002 | -22.40% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 3,386 | 84.52% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 528,502 | 7.13% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | -360,318 | -12.95% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,214 | 1,785.29% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 207,961 | 3.70% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 703 | 0.04% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 15,815 | 0.52% | $0.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 0 | -3,182,440 | -51.97% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -671,795 | -37.25% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 561,411 | 108.19% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 736,924 | 45.08% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | 44,197 | 4.96% | $0.00 |